Zou Chu Guo Men – Developing a Successful Strategy for Entering the U.S. Market
Foley is again proud to co-host the ChinaBio Executive Workshop in Guangzhou on April 19, 2011. This half-day, complimentary seminar will explore critical aspects of developing an effective going-out strategy and a plan to protect and leverage your life sciences technology and intellectual capital in the U.S. market. Topics include:
- Key 2010 developments in China’s life sciences industry and the current status of the Zou Chu Guo Men policy
- Entering the U.S. market via strategic alliances, joint ventures, direct investment, and other strategic collaborations
- Investing in life sciences companies in the United States
- Maximizing returns on investments via the art and science of patent prosecution
- Commercializing China-originated technology in the United States
スピーカー
- Hon. Sharon R. Barner, Foley Partner and Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director of the USPTO (2009 – 2011)
- Stephen A. Bent, Foley Partner and member of the firm’s Chemical, Biotechnology & Pharmaceutical Practice and Health Care and Nanotechnology Industry Teams
- James C. Chapman, Foley Partner and member of the firm’s Private Equity & Venture Capital Practice and Emerging Technologies Industry Team
- James F. Ewing, Foley Partner, Vice Chair of the firm’s Chemical, Biotechnology & Pharmaceutical Practice, and member of the firm’s Life Sciences, Food, and Nanotechnology Industry Teams
- Greg B. Scott, President and Founder, ChinaBio LLC
共同主催者：
For more information, contact Delia Dai at [email protected] or (001) 312.832.4506, or Monica Cheng at [email protected] or (86) 21.5137.0751.
